Citadel Advisors
STJ

Citadel Advisors’s St Jude Medical STJ Stock Holding History

Citadel Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-49,900
Closed -$3.96M – 8304
2016
Q3 		$3.98M Buy
49,900
+1,642
+3% +$133K ﹤0.01% 2213
2016
Q2 		$3.76M Buy
+48,258
New +$3.44M ﹤0.01% 2089
2016
Q1 		– Sell
-504,966
Closed -$27.5M – 8886
2015
Q4 		$31.2M Buy
504,966
+431,197
+585% +$27.2M 0.03% 596
2015
Q3 		$4.65M Sell
73,769
-494,720
-87% -$35.3M ﹤0.01% 2016
2015
Q2 		$41.5M Buy
568,489
+413,285
+266% +$29.9M 0.04% 582
2015
Q1 		$10.2M Sell
155,204
-61,993
-29% -$4.12M 0.01% 1437
2014
Q4 		$14.1M Sell
217,197
-137,840
-39% -$8.88M 0.01% 1159
2014
Q3 		$21.3M Buy
355,037
+104,157
+42% +$6.8M 0.02% 866
2014
Q2 		$17.4M Sell
250,880
-744,917
-75% -$48.3M 0.02% 896
2014
Q1 		$65.1M Buy
995,797
+555,721
+126% +$36.2M 0.08% 286
2013
Q4 		$27.3M Buy
440,076
+259,302
+143% +$15M 0.04% 639
2013
Q3 		$9.7M Buy
180,774
+174,245
+2,669% +$8.97M 0.01% 1127
2013
Q2 		$298K Buy
+6,529
New +$283K ﹤0.01% 4306

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citadel Advisors's STJ Position: Q4 2016 in Review

Citadel Advisors sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 49,900 shares — an estimated $3.96M sold.

Citadel Advisors first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $65.1M in Q1 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Citadel Advisors reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Citadel Advisors sold 49,900 St Jude Medical shares in Q4 2016, an estimated $3.96M.
  • Citadel Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Citadel Advisors's St Jude Medical position peaked at $65.1M in Q1 2014.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.